SBIR/STTR Research Award

Angiogenesis Scaffolding

Award identifier e8eeb98378f296375c7d50bd24a5419b273dca1fb6ecd2fda9595a6b3c122b92Awarding agency Department of Health and Human Services · National Institutes of Health

Award amount

$124,521

Program and phase

SBIR · Phase I

Award year

2003

Explore This Research Award in CaptureIQ

Research the technology, evaluate the recipient and agency, identify related opportunities, and explore potential follow-on work with CaptureIQ.

Award details

Awarding agency
Department of Health and Human Services
Branch
National Institutes of Health
Recipient company
NANOMATRIX, INC.
Proposal award date
Not reported
Contract end date
Not reported
UEI
Not reported
Solicitation number
Not reported
Topic code
Not reported

Research abstract

DESCRIPTION (provided by applicant): NanoMatrix, Inc and investigators at Virginia Commonwealth University (VCU) propose to use the process of electrospinning to fabricate electrospun collagen scaffolding designed to promote tissue regeneration. Ultimately, we believe this type of scaffold will serve as a solid-phase platform for the delivery of a variety of peptide factors and other agents to specific injury sites. Electrospinning has several distinct advantages; it is rapid and remarkably efficient. Electrospun fibrils of collagen appear to recapitulate many of the structural and functional properties of the native collagen fibril. Fibrils of electrospun collagen are 50-150 nm in diameter and exhibit a 65 nm repeat. To date this ultrastructural feature has not been reproduced in collagen fibrils that have been fabricated or otherwise polymerized in vitro by standard methods. This structural feature has only been observed in collagen deposited by cellular activity. An electrospun matrix of collagen is highly porous, will accept a suture, and is rapidly infiltrated by microvascular endothelial cells, events critical to the tissue-regeneration process. In preliminary experiments we demonstrate that it is possible to co-electrospin collagen and the growth factor vascular endothelial growth factor (VEGF) into a tissue-engineering scaffolding. This peptide is released from the collagen-based matrix over time and retains biological activity. When implanted, a VEGF-supplemented scaffolding is rapidly infiltrated by microvascular endothelial cells, functional capillaries. The Specific Aims of this Project are: Specific Aim 1. Tailor the controlled release of VEGF from an electrospun scaffold composed of Type I collagen and a PGNPLA copolymer blend. Specific Aim 2. Test electrospun scaffoldings supplemented with VEGF for angiogenic activity in the rabbit cornea.

Technology keywords

Not reported

Agency intelligence

Department of Health and Human Services

Back to SBIR/STTR Research Awards

Don't take our word for it. Ask AI about RFPCapture.

See what leading AI assistants have to say about RFPCapture and CaptureIQ.

Gemini opens without a prefilled question. The question is copied to your clipboard when the button works. You can also copy it here:

What is RFPCapture.com and its CaptureIQ platform from Smart Logic AI? How does it help federal contractors discover opportunities, evaluate bid/no-bid decisions, research government contracts, and prepare proposals? How does it compare with other federal capture platforms? Use independent sources where available.